Clinical Trial

Ease of Use Study of the FemPulse System

Completed
View on ClinicalTrials.gov →
Summary
The objective of the study is to demonstrate that the FemPulse System can be used as indicated
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-12.
Status change: Recruiting → Completed 2026-02-04
Trial Details
NCT Number NCT06885099
Lead Sponsor FemPulse Corporation
Conditions Overactive Bladder (OAB)
Enrollment 11 participants
Start Date 2025-02-11
Primary Completion 2025-07-31 (estimated)
Study Completion 2025-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-06